Back to results
US 2026/0218174 A1Published application
Omni Xl 1-22 CRISPR Nucleases
AssigneeEmendoBio Inc.
InventorNurit MERON
Life of this patent
Estimating the term…
Abstract
The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 90% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-22 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
Claims91
A non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 90% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs:
- 12, 16, 18, 19, 1-11, 13-15, 17, and 20-22, or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease, wherein the CRISPR nuclease further comprises one or more nuclear localization sequences (NLSs).
Dependencies are inferred from the claim text.